
Sign up to save your podcasts
Or


In this episode of Denatured, Dr. Peter Marks M.D., PhD. gives his thoughts on the future of cell and gene therapies. He speaks candidly about opportunities and realities, manufacturing and its role in efficacy and the CGT runway.
Dr. Marks was keynote speaker at the GenScript Biotech Forum in San Francisco this week.
Host
Lori Ellis, Head of Insights, BioSpace
Guest
Peter Marks M.D., PhD., Director, Center for Biologics Evaluation and Research (CBER)
By BioSpace4.9
1313 ratings
In this episode of Denatured, Dr. Peter Marks M.D., PhD. gives his thoughts on the future of cell and gene therapies. He speaks candidly about opportunities and realities, manufacturing and its role in efficacy and the CGT runway.
Dr. Marks was keynote speaker at the GenScript Biotech Forum in San Francisco this week.
Host
Lori Ellis, Head of Insights, BioSpace
Guest
Peter Marks M.D., PhD., Director, Center for Biologics Evaluation and Research (CBER)

90,994 Listeners

30,666 Listeners

43,528 Listeners

8,776 Listeners

970 Listeners

4,345 Listeners

1,170 Listeners

1,967 Listeners

56,508 Listeners

9,532 Listeners

337 Listeners

6,089 Listeners

6,564 Listeners

34 Listeners

23 Listeners